Fidelity Investments’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
133,566
+50,670
+61% +$573K ﹤0.01% 2585
2025
Q1
$957K Buy
82,896
+891
+1% +$10.3K ﹤0.01% 2693
2024
Q4
$695K Buy
82,005
+15,582
+23% +$132K ﹤0.01% 2795
2024
Q3
$769K Buy
66,423
+12,397
+23% +$144K ﹤0.01% 2688
2024
Q2
$636K Buy
54,026
+3,119
+6% +$36.7K ﹤0.01% 2648
2024
Q1
$604K Sell
50,907
-63
-0.1% -$747 ﹤0.01% 2658
2023
Q4
$624K Sell
50,970
-6,596
-11% -$80.8K ﹤0.01% 2609
2023
Q3
$554K Sell
57,566
-13,299
-19% -$128K ﹤0.01% 2602
2023
Q2
$638K Sell
70,865
-30
-0% -$270 ﹤0.01% 2584
2023
Q1
$557K Sell
70,895
-1,240,107
-95% -$9.75M ﹤0.01% 2656
2022
Q4
$8.86M Buy
1,311,002
+152,617
+13% +$1.03M ﹤0.01% 1940
2022
Q3
$16.8M Buy
1,158,385
+25,943
+2% +$376K ﹤0.01% 1668
2022
Q2
$11.1M Buy
1,132,442
+307,092
+37% +$3.02M ﹤0.01% 1927
2022
Q1
$12.2M Buy
825,350
+38,130
+5% +$562K ﹤0.01% 2035
2021
Q4
$10.4M Sell
787,220
-173,741
-18% -$2.3M ﹤0.01% 2098
2021
Q3
$16.8M Sell
960,961
-127,829
-12% -$2.23M ﹤0.01% 1922
2021
Q2
$26.1M Sell
1,088,790
-259,180
-19% -$6.21M ﹤0.01% 1729
2021
Q1
$34.6M Sell
1,347,970
-292,308
-18% -$7.51M ﹤0.01% 1549
2020
Q4
$31.1M Sell
1,640,278
-101,335
-6% -$1.92M ﹤0.01% 1518
2020
Q3
$21.9M Sell
1,741,613
-22,243
-1% -$280K ﹤0.01% 1523
2020
Q2
$21.3M Sell
1,763,856
-26,935
-2% -$326K ﹤0.01% 1524
2020
Q1
$13.7M Buy
1,790,791
+123,813
+7% +$947K ﹤0.01% 1571
2019
Q4
$29.7M Buy
1,666,978
+742,033
+80% +$13.2M ﹤0.01% 1440
2019
Q3
$10.7M Sell
924,945
-51,535
-5% -$598K ﹤0.01% 1799
2019
Q2
$21.6M Buy
976,480
+241,466
+33% +$5.35M ﹤0.01% 1597
2019
Q1
$21M Buy
+735,014
New +$21M ﹤0.01% 1588
2016
Q2
Sell
-139,432
Closed -$1.26M 2672
2016
Q1
$1.26M Sell
139,432
-100,936
-42% -$909K ﹤0.01% 2451
2015
Q4
$12.2M Buy
240,368
+2,765
+1% +$140K ﹤0.01% 1910
2015
Q3
$11.9M Buy
237,603
+1,408
+0.6% +$70.4K ﹤0.01% 1884
2015
Q2
$23.6M Buy
+236,195
New +$23.6M ﹤0.01% 1664